Last reviewed · How we verify
NCT07330830: AdipoDROMExpo
Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)
trial in MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) in 600 participants. Currently enrolling.
26 November 2027
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Guadeloupe |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 26 November 2025 |
| Primary completion | 26 November 2027 |
| Estimated completion | 28 November 2027 |
| Sites | 3 locations across French Guiana, Guadeloupe, Reunion |
Conditions studied
- MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) — all drugs for MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) →
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Who can join
18 and older, any sex, with MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Metabolic Dysfunction Associated Liver Disease (MASLD) is associated with metabolic syndrome, and PNPLA3 variants are known to be implicated in intrahepatic lipid accumulation and linked to lipotoxicity. Analysis of PNPLA3 polymorphisms in an overseas territories population of MASLD would be interesting to describe their profile susceptibility to develop Metabolic dysfunction associated steatohepatitis (MASH).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07330830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Currently open trials in the same condition.
- NCT07280143 — The Development of MASLD Among Survivors of Breast or Colorectal Cancer · recruiting
- NCT07321925 — Thermoacoustic Method for Estimating Liver Fat Fraction · recruiting
- NCT07070362 — Digital Early Warning System for Acute Lung Injury in Liver Surgery · recruiting
Other Centre Hospitalier Universitaire de la Guadeloupe trials
Trials by the same sponsor.
- NCT07266376 — Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS · NA · not yet recruiting
- NCT07292454 — Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe · not yet recruiting
- NCT07265986 — Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart · NA · recruiting
- NCT07233447 — Prevalence of H. Pylori in Stomach Cancers in the West Indies · recruiting
- NCT07001189 — Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07330830 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Guadeloupe
- Last refreshed: 9 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07330830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing